Journal article
Functional neuroimaging biomarkers of anhedonia response to escitalopram plus adjunct aripiprazole treatment for major depressive disorder
Abstract
BACKGROUND: Identifying neuroimaging biomarkers of antidepressant response may help guide treatment decisions and advance precision medicine.
AIMS: To examine the relationship between anhedonia and functional neurocircuitry in key reward processing brain regions in people with major depressive disorder receiving aripiprazole adjunct therapy with escitalopram.
Authors
Vaccarino SR; Wang S; Rizvi SJ; Lou W; Hassel S; MacQueen GM; Ho K; Frey BN; Lam RW; Milev RV
Journal
BJPsych Open, Vol. 10, No. 1,
Publisher
Royal College of Psychiatrists
Publication Date
1 2024
DOI
10.1192/bjo.2023.588
ISSN
2056-4724